155 related articles for article (PubMed ID: 38308396)
21. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
Panek CM; Nakamura RK; Bianco D
J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
[TBL] [Abstract][Full Text] [Related]
22. Influence of immune-mediated hemolytic anemia on flow velocities in the portal vein and caudal vena cava measured by use of pulsed-wave Doppler ultrasonography in dogs.
Smith RP; Koenigshof AM; Smith DJ; Strom PR; Nelson NC
Am J Vet Res; 2018 May; 79(5):518-524. PubMed ID: 29688778
[TBL] [Abstract][Full Text] [Related]
23. Immune-mediated haemolytic anaemia and thrombocytopenia in 25 adult equids: 1997-2016.
Easton-Jones CA; Estell KE; Magdesian KG
Equine Vet J; 2021 Sep; 53(5):964-971. PubMed ID: 33169417
[TBL] [Abstract][Full Text] [Related]
24. Vaccination and Associated Adverse Events in Dogs Previously Treated for Primary Immune-Mediated Hemolytic Anemia.
Moon A; Veir J
J Am Anim Hosp Assoc; 2019; 55(1):29-34. PubMed ID: 30427712
[TBL] [Abstract][Full Text] [Related]
25. Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia.
Zoia A; Gerou-Ferriani M; Drigo M; Caldin M
J Am Vet Med Assoc; 2018 Jun; 252(11):1384-1392. PubMed ID: 29772969
[TBL] [Abstract][Full Text] [Related]
26. Procoagulant microparticles in dogs with immune-mediated hemolytic anemia.
Kidd L; Geddings J; Hisada Y; Sueda M; Concannon T; Nichols T; Merricks E; Mackman N
J Vet Intern Med; 2015; 29(3):908-16. PubMed ID: 25871966
[TBL] [Abstract][Full Text] [Related]
27. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990).
Klag AR; Giger U; Shofer FS
J Am Vet Med Assoc; 1993 Mar; 202(5):783-8. PubMed ID: 8454517
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic immune-mediated thrombocytopenia and recent vaccination in dogs.
Huang AA; Moore GE; Scott-Moncrieff JC
J Vet Intern Med; 2012; 26(1):142-8. PubMed ID: 22151468
[TBL] [Abstract][Full Text] [Related]
29. Case-control study of blood type, breed, sex, and bacteremia in dogs with immune-mediated hemolytic anemia.
Miller SA; Hohenhaus AE; Hale AS
J Am Vet Med Assoc; 2004 Jan; 224(2):232-5. PubMed ID: 14736067
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin G and phosphatidylserine in regenerative and nonregenerative immune-mediated anemias of dogs.
Lucidi CA; Gerlach JA; Jutkowitz A; Scott MA
J Vet Intern Med; 2021 Nov; 35(6):2713-2721. PubMed ID: 34716708
[TBL] [Abstract][Full Text] [Related]
31. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia.
Whelan MF; O'Toole TE; Chan DL; Rozanski EA; DeLaforcade AM; Crawford SL; Cotter SM
J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):158-64. PubMed ID: 19691566
[TBL] [Abstract][Full Text] [Related]
32. The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.
Paes G; Paepe D; Meyer E; Kristensen AT; Duchateau L; Campos M; Daminet S
Acta Vet Scand; 2013 Oct; 55(1):74. PubMed ID: 24160183
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia.
Griebsch C; Arndt G; Raila J; Schweigert FJ; Kohn B
Vet Clin Pathol; 2009 Dec; 38(4):421-5. PubMed ID: 19392754
[TBL] [Abstract][Full Text] [Related]
34. Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia.
Tan E; Bienzle D; Shewen P; Kruth S; Wood D
Vet Clin Pathol; 2012 Mar; 41(1):45-55. PubMed ID: 22315967
[TBL] [Abstract][Full Text] [Related]
35. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.
Swann JW; Garden OA; Fellman CL; Glanemann B; Goggs R; LeVine DN; Mackin AJ; Whitley NT
J Vet Intern Med; 2019 May; 33(3):1141-1172. PubMed ID: 30847984
[TBL] [Abstract][Full Text] [Related]
36. The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia.
Bestwick JP; Sharman M; Whitley NT; Kisielewicz C; Skelly BJ; Tappin S; Kellett-Gregory L; Seth M
J Vet Intern Med; 2022 Jan; 36(1):78-85. PubMed ID: 34779044
[TBL] [Abstract][Full Text] [Related]
37. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.
Garden OA; Kidd L; Mexas AM; Chang YM; Jeffery U; Blois SL; Fogle JE; MacNeill AL; Lubas G; Birkenheuer A; Buoncompagni S; Dandrieux JRS; Di Loria A; Fellman CL; Glanemann B; Goggs R; Granick JL; LeVine DN; Sharp CR; Smith-Carr S; Swann JW; Szladovits B
J Vet Intern Med; 2019 Mar; 33(2):313-334. PubMed ID: 30806491
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic utility of thoracic radiographs and abdominal ultrasound in canine immune-mediated hemolytic anemia.
Andres M; Hostnik E; Green E; Langston C; Parker VJ; Gilor C; Rudinsky AJ
Can Vet J; 2019 Oct; 60(10):1065-1071. PubMed ID: 31597991
[TBL] [Abstract][Full Text] [Related]
39. Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry.
Goggs R; Dennis SG; Di Bella A; Humm KR; McLauchlan G; Mooney C; Ridyard A; Tappin S; Walker D; Warman S; Whitley NT; Brodbelt DC; Chan DL
J Vet Intern Med; 2015; 29(6):1603-10. PubMed ID: 26473338
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
